Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-19 Mills Kenneth T. President and CEO Exercise or conversion +5,000 $0.85 $4K 251,000
2019-09-19 Mills Kenneth T. President and CEO Sale −2,227 $39.19 $87K 248,773
2019-09-19 Mills Kenneth T. President and CEO Sale −7,773 $39.91 $310K 241,000
2019-09-19 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −5,000 79,670
2019-09-12 Christmas Patrick J. SVP, General Counsel Exercise or conversion +5,000 $12.10 $61K 8,058
2019-09-12 Christmas Patrick J. SVP, General Counsel Sale −5,486 $42.00 $230K 2,572
2019-09-12 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −5,000 39,931
2019-08-19 Mills Kenneth T. President and CEO Exercise or conversion +15,000 $0.85 $13K 261,000
2019-08-19 Mills Kenneth T. President and CEO Sale −14,624 $37.54 $549K 246,376
2019-08-19 Mills Kenneth T. President and CEO Sale −376 $37.92 $14K 246,000
2019-08-19 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 84,670
2019-07-19 Mills Kenneth T. President and CEO Exercise or conversion +15,000 $0.85 $13K 261,000
2019-07-19 Mills Kenneth T. President and CEO Sale −12,700 $49.40 $627K 248,300
2019-07-19 Mills Kenneth T. President and CEO Sale −2,300 $49.97 $115K 246,000
2019-07-19 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 99,670
2019-07-19 Christmas Patrick J. SVP, General Counsel Exercise or conversion +4,900 $19.50 $96K 7,958
2019-07-19 Christmas Patrick J. SVP, General Counsel Sale −4,900 $50.03 $245K 3,058
2019-07-19 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Stock Option (Right to Buy) −4,900 4,641
2019-07-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion +100 $19.50 $2K 3,158
2019-07-18 Christmas Patrick J. SVP, General Counsel Sale −100 $50.00 $5K 3,058

Page 26 of 43 · 852 trades